Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) (Q24241438)

26 July 2017

0 references

1 reference

title

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) (English)

0 references

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). (English)

1 reference

26 July 2017

1 reference

6

Zulfiqar A Bhutta

1 reference

26 July 2017

Julia A Critchley

3

1 reference

26 July 2017

2

Anita KM Zaidi

0 references

Anita Zaidi

series ordinal

2

object named as

Anita Km Zaidi

1 reference

26 July 2017

Durrane Thaver

1

1 reference

26 July 2017

Asma Azmatullah

series ordinal

4

1 reference

26 July 2017

Syed Ali Madni

series ordinal

5

1 reference

26 July 2017

publication date

8 October 2008

1 reference

Cochrane Database of Systematic Reviews

26 July 2017

published in

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

CD004530

1 reference

A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Pefloxacin versus chloramphenicol in the therapy of typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Short courses of ofloxacin for the treatment of enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Randomized treatment of patients with typhoid and paratyphoid fevers using norfloxacin or chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

A randomized comparative study of fleroxacin and ceftriaxone in enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Comparison of two regimens for ciprofloxacin treatment of enteric infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin in typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fleroxacin vs Ciprofloxacin in the Management of Typhoid Fever: A Randomised, Open, Comparative Study in Nigerian Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Multidrug-resistant typhoid fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin versus chloramphenicol in the treatment of salmonella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolone-resistant Salmonella Paratyphi A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Experts call for surveillance of drug-resistant typhoid at a global level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Impact of age and drug resistance on mortality in typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Bacteremic typhoid fever in children in an urban slum, Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin resistance in Salmonella paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin treatment failure in typhoid fever case, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Drug-resistant Salmonella enterica serotype paratyphi A in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Enteric fever treatment failures: a global concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

The use of systemic fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolones: considerations for future use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolone resistance in Salmonella Typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolone adverse effects and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolones in paediatrics: a risk for the patient or for the community?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Paratyphoid fever in Vellore, South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Salmonella paratyphi A rates, Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Enteric fever in Mumbai, India: the good news and the bad news

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ciprofloxacin-resistant Salmonella typhi in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Typhoid fever in Bangladesh: implications for vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Typhoid fever in children aged less than 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Re-emergence of chloramphenicol-sensitive Salmonella typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Publication bias: evidence of delayed publication in a cohort study of clinical research projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Current perspectives of enteric fever: a hospital-based study from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu, Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

7 January 2021

Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

7 January 2021

Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

7 January 2021

Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

7 January 2021

Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB3

7 January 2021

10.1002/14651858.CD004530.PUB3

Identifiers

DOI

1 reference

26 July 2017

1 reference